Inventor
STROM TERRY B
US30 patents
⚠️ This page may combine multiple inventors who share the name “STROM TERRY B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BETH ISRAEL HOSPITAL
23 patentsUS6403077B1Jun 11, 2002
Treatment regimes featuring an IL-10-containing chimeric polypeptide
BETH ISRAEL HOSPITAL89 citations97
US6165476ADec 26, 2000
Fusion proteins with an immunoglobulin hinge region linker
BETH ISRAEL HOSPITAL117 citations97
US5674494AOct 7, 1997
Treating non-malignant disease states with IL-2 receptor-specific substances
BETH ISRAEL HOSPITAL26 citations96
US5510105AApr 23, 1996
Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxins
BETH ISRAEL HOSPITAL30 citations96
US5336489AAug 9, 1994
Treatment of allograft rejection with IL-2 receptor-specific cytotoxins
BETH ISRAEL HOSPITAL26 citations96
US6998476B2Feb 14, 2006
Nucleic acids encoding antagonists of interleukin-15
BETH ISRAEL HOSPITAL33 citations95
US6451308B1Sep 17, 2002
Antagonists of interleukin-15
BETH ISRAEL HOSPITAL54 citations95
US6410008B1Jun 25, 2002
Chimeric IL-10 proteins and uses thereof
BETH ISRAEL HOSPITAL48 citations95
US6001973ADec 14, 1999
Antagonists of interleukin-15
BETH ISRAEL HOSPITAL69 citations95
US7834152B2Nov 16, 2010
Antagonists of interleukin-15
BETH ISRAEL HOSPITAL22 citations92
US7258853B2Aug 21, 2007
Antagonists of interleukin-15
BETH ISRAEL HOSPITAL28 citations92
US6770272B2Aug 3, 2004
Treatment of diabetes
BETH ISRAEL HOSPITAL24 citations92
US5607675AMar 4, 1997
Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxin
BETH ISRAEL HOSPITAL21 citations92
US5011684AApr 30, 1991
Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
BETH ISRAEL HOSPITAL39 citations92
US7347995B2Mar 25, 2008
Compositions and methods for achieving immune suppression
BETH ISRAEL HOSPITAL22 citations90
US6797263B2Sep 28, 2004
Compositions and methods for achieving immune suppression
BETH ISRAEL HOSPITAL33 citations90
US5152980AOct 6, 1992
Induction of tolerance to a foreign antigen IL-2 receptor-binding substances
BETH ISRAEL HOSPITAL41 citations89
US5916559AJun 29, 1999
Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection
BETH ISRAEL HOSPITAL15 citations82
US5587162ADec 24, 1996
Treatment of allograft rejection with IL-2 receptor-specific cytotoxins
BETH ISRAEL HOSPITAL16 citations82
US7579439B2Aug 25, 2009
Modulation of IL-2- and IL-15-mediated T cell responses
BETH ISRAEL HOSPITAL16 citations80
US6113900ASep 5, 2000
Use of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disorders
BETH ISRAEL HOSPITAL8 citations74
US7018626B2Mar 28, 2006
Chimeric IL-10
BETH ISRAEL HOSPITAL4 citations73
US5936138AAug 10, 1999
Gene encoding mutant L3T4 protein which facilitates HIV infection and transgenic mouse expressing such protein
BETH ISRAEL HOSPITAL5 citations69